吉姆·克雷默：
持有builders firstsource股票，viking therapeutics存在问题。
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
On Aug. 28, Serve Robotics announced closing of $20 million private placement & warrant exercise.On CNBC's "Mad Money Lightning Round," Jim Cramer said Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is "great."
在CNBC的“狂欢现场”中，吉姆·克雷默表示福泰制药公司(NASDAQ: VRTX)非常出色。
On Aug. 1, Vertex Pharmaceuticals reported second-quarter revenues of $2.65 billion, almost in line with the consensus of estimate of $2.66 billion. Vertex raised its 2024 product revenue guidance from $10.55 billion-$10.75 billion to $10.65 billion-$10.85 billion.
福泰制药于8月1日发布了第二季度营收265亿元，几乎与预估的266亿元一致。福泰制药将2024年产品营业收入预期从105.5亿美元至107.5亿美元调高至106.5亿美元至108.5亿美元。
When asked about Serve Robotics Inc. (NASDAQ:SERV), he said, "We're not recommending companies that lose a ton of money because it's just not the right time."
当被问到是否推荐Serve Robotics公司(NASDAQ:SERV)时，他说：“因为现在不是合适的时机，我们不建议那些亏损的公司。”
On Aug. 28, Serve Robotics announced closing of $20 million private placement & warrant exercise.
在8月28日，Serve Robotics宣布完成了2000万元定向增发和权证行使。
Builders FirstSource, Inc. (NYSE:BLDR) can "go higher," Cramer said, "This is precisely the kind of stock you should be buying at this stage in the cycle. Hold on."
吉姆·克雷默说，Builders FirstSource公司(NYSE:BLDR)的股价可以“上涨”，“这正是你在这个阶段应该购买的股票。继续持有。”
On Aug. 6, Builders FirstSource reported second-quarter adjusted earnings per share of $3.50, beating the street view of $3.02. Quarterly sales of $4.456 billion missed the street view of $4.483 billion.
8月6日，Builders FirstSource报道了每股调整后的第二季度收益为3.50美元，超过了3.02美元的预期。季度销售额4456亿元低于4483亿元的预期。
"Here's the problem: it costs so much money to build the factories, they're going to have to get a takeover to be able to do that," Cramer said about Viking Therapeutics, Inc. (NASDAQ:VKTX).
吉姆·克雷默谈到Viking Therapeutics公司(NASDAQ:VKTX)时表示：“问题是，建厂的费用太高了，他们必须进行收购才能做到这一点。”
On July 24, Viking Therapeutics reported better-than-expected second-quarter EPS results.
7月24日，Viking Therapeutics发布了超出预期的第二季度每股收益结果。
Price Action:
价格行动：
- Serve Robotics shares fell 1.3% to settle at $9.35 on Wednesday.
- Builders FirstSource shares fell 1% to close at $172.90.
- Vertex Pharmaceuticals shares gained 2% to close at $489.73.
- Viking Therapeutics shares fell 0.4% to settle at $61.16 on Wednesday.
- Serve Robotics股票在周三下跌1.3%，收于9.35美元。
- Builders FirstSource股票下跌1%，收于172.90美元。
- Vertex Pharmaceuticals股票上涨2%，收于489.73美元。
- Viking Therapeutics股票在周三下跌0.4%，收于61.16美元。
- Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
- 华尔街最准确的分析师聚焦于3家材料股，提供高股息回报。
资讯热榜
更新时间